Winslow Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,921
Closed -$202K 74
2023
Q1
$202K Hold
2,921
0.05% 67
2022
Q4
$210K Hold
2,921
0.05% 72
2022
Q3
$208K Sell
2,921
-1,100
-27% -$79.8K 0.05% 70
2022
Q2
$310K Hold
4,021
0.07% 64
2022
Q1
$294K Sell
4,021
-485
-11% -$32.6K 0.06% 73
2021
Q4
$281K Hold
4,506
0.05% 76
2021
Q3
$267K Hold
4,506
0.05% 77
2021
Q2
$301K Hold
4,506
0.06% 70
2021
Q1
$284K Hold
4,506
0.06% 69
2020
Q4
$280K Hold
4,506
0.06% 69
2020
Q3
$272K Sell
4,506
-99
-2% -$5.96K 0.07% 67
2020
Q2
$271K Sell
4,605
-102
-2% -$6.1K 0.07% 66
2020
Q1
$262K Sell
4,707
-350
-7% -$21.4K 0.09% 68
2019
Q4
$325K Buy
5,057
+201
+4% +$11.5K 0.07% 75
2019
Q3
$246K Sell
4,856
-400
-8% -$18.8K 0.06% 77
2019
Q2
$238K Sell
5,256
-150
-3% -$6.99K 0.05% 79
2019
Q1
$258K Hold
5,406
0.05% 78
2018
Q4
$281K Hold
5,406
0.07% 80
2018
Q3
$336K Sell
5,406
-200
-4% -$11.9K 0.06% 77
2018
Q2
$310K Hold
5,606
0.06% 80
2018
Q1
$355K Hold
5,606
0.07% 74
2017
Q4
$344K Hold
5,606
0.06% 76
2017
Q3
$357K Sell
5,606
-1,000
-15% -$58.4K 0.07% 77
2017
Q2
$368K Buy
6,606
+320
+5% +$17.4K 0.07% 75
2017
Q1
$342K Sell
6,286
-151
-2% -$8.28K 0.07% 76
2016
Q4
$376K Buy
6,437
+151
+2% +$8.26K 0.08% 74
2016
Q3
$339K Hold
6,286
0.07% 75
2016
Q2
$462K Sell
6,286
-200
-3% -$14.1K 0.1% 73
2016
Q1
$414K Sell
6,486
-850
-12% -$53.6K 0.09% 72
2015
Q4
$505K Hold
7,336
0.1% 69
2015
Q3
$434K Sell
7,336
-70
-0.9% -$4.44K 0.09% 69
2015
Q2
$493K Hold
7,406
0.09% 70
2015
Q1
$478K Hold
7,406
0.08% 70
2014
Q4
$437K Hold
7,406
0.07% 72
2014
Q3
$379K Hold
7,406
0.07% 71
2014
Q2
$359K Hold
7,406
0.06% 74
2014
Q1
$385K Hold
7,406
0.07% 71
2013
Q4
$394K Hold
7,406
0.07% 67
2013
Q3
$343K Hold
7,406
0.07% 68
2013
Q2
$331K Buy
+7,406
New +$322K 0.07% 69

Other funds holding BMY

Winslow Asset Management's BMY Position: Q2 2023 in Review

Winslow Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 2,921 shares — an estimated $202K sold.

Winslow Asset Management first reported a position in BMY in Q2 2013 and held it in 40 quarters. The position peaked at $505K in Q4 2015. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Winslow Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Winslow Asset Management sold 2,921 Bristol-Myers Squibb shares in Q2 2023, an estimated $202K.
  • Winslow Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 40 quarters.
  • Winslow Asset Management's Bristol-Myers Squibb position peaked at $505K in Q4 2015.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Winslow Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.